Dr. Reddy's Laboratories Makes Five-Year Commitment to I-many's Contract Lifecycle Management Solutions.Dr. Reddy's to Implement Latest Generation of I-many CARS([R]), I-many Medicaid[TM], I-many Government Pricing[TM], and I-many Contract Manager[TM] EDISON, N.J. -- I-many, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :IMNY IMNY Internet Marketers of New York ), the leading provider of advanced Contract Lifecycle Management (CLM CLM - Career Limiting Move ) solutions for managing corporate commitments, today announced that Dr. Reddy's Laboratories Dr. Reddy’s Laboratories Ltd. (Reddy's), founded in 1984 by Dr. K. Anji Reddy, has become India’s third biggest pharmaceutical company. Reddy had worked in the publicly-owned Indian Drugs and Pharmaceuticals Ltd. has signed a five-year agreement to license I-many's latest generation CLM solutions, which include I-many CARS, I-many Medicaid, I-many Government Pricing, and I-many Contract Manager. The commitment is a key element in Dr. Reddy's ongoing drive to optimize revenues and increase market share in the U.S. "Dr. Reddy's has been a very loyal customer of I-many solutions since 2002 and have chosen to broaden their commitment to I-many's Contract Lifecycle Management solutions as they seek ways to profitably extend their presence in the U.S. pharmaceutical marketplace," said David Blumberg, I-many's executive vice president of fulfillment services. "The latest generation of I-many products offer increased performance, while also providing an integrated architecture across all elements in our entire CLM foundation. As a result, all contract-related activities can be streamlined, and administrative overhead will be cut significantly. In addition, these latest generation products also feature a Web-browser interface that minimizes training and dramatically simplifies use of the system." I-many's CLM solutions are designed to help companies like Dr. Reddy's Laboratories to optimize revenues associated with rebates, chargebacks, and accurate pricing, while also ensuring compliance with a range of regulations, including Medicaid and the federal Deficit Reduction Act (DRA DRA Delta Regional Authority DRA Developmental Reading Assessment (educational test) DRA Division of Ratepayer Advocates (California) DRA Data Research Associates DRA Directory and Resource Administrator ). With I-many Contract Manager, Dr. Reddy's will be able to automate processing of all enterprise contracts, including those with employees, suppliers, and customers. "Dr. Reddy's is focused on cost-effective and efficient growth, achieved by optimizing revenue within the bounds of compliance," said John Rade John Rade, (born August 31, 1960, in Ceres, California) was a linebacker in the NFL from 1983 to 1991. , I-many's president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "As they join a growing number of top tier pharmaceutical companies making the switch to the latest generation of I-many's Contract Lifecycle Management solutions, we are confident that these goals will be met." About Dr. Reddy's Laboratories Established in 1984, Dr. Reddy's Laboratories (NYSE NYSE See: New York Stock Exchange : RDY RDY Ready ) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia. The company conducts research in the areas of diabetes, cardiovascular, anti-infectives, inflammation and cancer. For more information, visit www.drreddys.com. About I-many([R]) I-many (NASDAQ:IMNY) is the leading provider of advanced Contract Lifecycle Management solutions for managing corporate commitments. Designed to extend beyond the traditional contract management capabilities, I-many ContractSphere([R]) offers an end-to-end solution (jargon) end-to-end solution - (E2ES) A term that suggests that the supplier of an application program or system will provide all the hardware and/or software components and resouces to meet the customer's requirement and no other supplier need be involved. Compare: turn-key solution. , from pre-contract processes and contract management to transaction compliance. Ultimately, this provides companies with the visibility and control needed to manage any type of commitment - from contracts and obligations to payments and collections. The result is increased revenue, minimized risk and dramatically reduced operating costs operating costs npl → gastos mpl operacionales , which deliver improved profitability with hard return on investment. More than 280 customers across 21 industries worldwide have implemented and realized the value of I-many business solutions. For more information, please visit www.imany.com. This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include: the risk of unforeseen technical or practical impediments to planned software development and other risk factors set forth from time to time in the Company's filings with the Securities and Exchange Commission. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion